FDA
label_change
· 2018-09-14
FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
Summary
FDA approved a supplemental application for zolpidem tartrate by Sanofi-Aventis U.S. LLC to update the labeling of the approved insomnia medication.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZOLPIDEM TARTRATE (ZOLPIDEM TARTRATE)